LITAF protects against pore-forming protein–induced cell death by promoting membrane repair
Science Immunology · 12.01.2024 · 9 (91)
DOI: 10.1126/sciimmunol.abq6541 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, erschienen am 12.01.2024. Verfasst von Caroline Stefani und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Systems Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA. Hauptthemen laut MEDLINE: Pyroptosis, Bacterial Toxins. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Pore-forming toxins (PFTs) are the largest class of bacterial toxins and contribute to virulence by triggering host cell death. Vertebrates also express endogenous pore-forming proteins that induce cell death as part of host defense. To mitigate damage and promote survival, cells mobilize membrane repair mechanisms to neutralize and counteract pores, but how these pathways are activated is poorly understood. Here, we use a transposon-based gene activation screen to discover pathways that counteract the cytotoxicity of the archetypal PFT Staphylococcus aureus α-toxin. We identify the endolysosomal protein LITAF as a mediator of cellular resistance to PFT-induced cell death that is active against both bacterial toxins and the endogenous pore, gasdermin D, a terminal effector of pyroptosis. Activation of the ubiquitin ligase NEDD4 by potassium efflux mobilizes LITAF to recruit the endosomal sorting complexes required for transport (ESCRT) machinery to repair damaged membrane. Cells lacking LITAF, or carrying naturally occurring disease-associated mutations of LITAF, are highly susceptible to pore-induced death. Notably, LITAF-mediated repair occurs at endosomal membranes, resulting in expulsion of damaged membranes as exosomes, rather than through direct excision of pores from the surface plasma membrane. These results identify LITAF as a key effector that links sensing of cellular damage to repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Systems Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA.
- Department of Immunology, University of Washington, Seattle, WA, USA.
- Institute for Protein Design, Department of Biochemistry, University of Washington, Seattle, WA, USA.
ORCID-Profile: Caroline Stefani, Anna M Bruchez, Mario G Rosasco, Anna E Yoshida, Kayla J Fasano, Alina Lorant, Nicholas W Hubbard, Andrew Oberst, Adam Lacy-Hulbert
Förderung
- NIGMS NIH HHS
- NIAID NIH HHS
Zitieren
APA
Stefani, C., Bruchez, A. M., Rosasco, M. G., Yoshida, A. E., Fasano, K. J., Levan, P. F., Lorant, A., Hubbard, N. W., Oberst, A., Stuart, L. M., & Lacy-Hulbert, A. (2024). LITAF protects against pore-forming protein–induced cell death by promoting membrane repair. Science Immunology, 9(91). https://doi.org/10.1126/sciimmunol.abq6541
Vancouver
Stefani C, Bruchez AM, Rosasco MG, Yoshida AE, Fasano KJ, Levan PF, et al. LITAF protects against pore-forming protein–induced cell death by promoting membrane repair. Science Immunology. 2024;9(91). doi:10.1126/sciimmunol.abq6541
BibTeX
@article{Stefani2024,
author = {Stefani, Caroline and Bruchez, Anna M and Rosasco, Mario G and Yoshida, Anna E and Fasano, Kayla J and Levan, Paula F and Lorant, Alina and Hubbard, Nicholas W and Oberst, Andrew and Stuart, Lynda M and Lacy-Hulbert, Adam},
title = {LITAF protects against pore-forming protein–induced cell death by promoting membrane repair},
journal = {Science Immunology},
year = {2024},
volume = {9},
number = {91},
doi = {10.1126/sciimmunol.abq6541}
}
EUVIMED